Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Relugolix for Endometriosis Associated Pain

View source ↗

Summary

A clinical trial update indicates that the study NCT07440043 evaluating relugolix for endometriosis-associated pain is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Relugolix (Relugolix)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Endometriosis, Endometriosis-related Pain | Status: NOT_YET_RECRUITING